SRPTSarepta Therapeutics, Inc.

$2B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M

Gross Profit

$16M98.5% margin

Operating Income

-$39M-240.1% margin

Net Income

$84M514.6% margin

EPS (Diluted)

$1.50

QoQ Revenue Growth

+201.5%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$64M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$512M

Total Liabilities

$82M

Stockholders' Equity

$429M

Cash & Equivalents

$275M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$0	—
Gross Profit	$16M	-$38M	+142.0%
Operating Income	-$39M	-$60M	+34.3%
Net Income	$84M	-$60M	+240.7%

SRPT Q1 2017 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena